TIL,a new modality aproved in US
A new modality for new drugs, TILs (tumour-infiltrating lymphocytes), has also been commercialised, and the impact of TILs finally reaching commercialisation after 37 years is analysed.
https://miyata-bio.net/column/0000325/
この記事が気に入ったらサポートをしてみませんか？